Creative Planning
ORKA

Creative Planning’s Oruka Therapeutics ORKA Stock Holding History

Creative Planning’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$625K Buy
12,736
+5,040
+65% +$175K ﹤0.01% 2851
2025
Q4 		$233K Buy
+7,696
New +$214K ﹤0.01% 3432
2017
Q3 		– Hold
0
– – – 3788
2017
Q2 		– Hold
0
– – – 4867
2017
Q1 		– Hold
0
– – – 4943
2016
Q4 		– Sell
-1
Closed -$532 – 4879
2016
Q3 		$0 Hold
1
– – ﹤0.01% 4761
2016
Q2 		$0 Buy
+1
New +$740 ﹤0.01% 4554

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Creative Planning's ORKA Position: Q1 2026 in Review

Creative Planning increased its Oruka Therapeutics (ORKA) stake by 65% in Q1 2026, buying an estimated $175K and bringing the position to 12,736 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #2851.

Creative Planning first reported a position in ORKA in Q2 2016 and has held it in 4 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Creative Planning held 12,736 shares of Oruka Therapeutics worth $625K as of Q1 2026.
  • Creative Planning bought 5,040 Oruka Therapeutics shares in Q1 2026, an estimated $175K.
  • Oruka Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2851 holding.
  • Creative Planning first reported a position in Oruka Therapeutics in Q2 2016 and has held it in 4 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.